Trends in Initiation of Disease‐Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among Commercially Insured Adults in the United States, 2001–2021
Expanded DMARD options over the last two decades have led to decreased csDMARD initiations and increased b/tsDMARD initiations, reflecting patient- and system-level factors.
Authors
- Daniel B. Horton (ORCID: https://orcid.org/0000-0002-1831-1339)
- Louis Yong Yu Lee (ORCID: https://orcid.org/0009-0007-9183-6709)
- Priyanka Yalamanchili (ORCID: https://orcid.org/0000-0002-5290-8665)
- Zeba Khan (ORCID: https://orcid.org/0000-0001-9616-7654)
- Chintan Dave
- Jeffrey A. Sparks
- Joseph G. Barone
Institutions
- Rutgers, The State University of New Jersey (US)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Johnson University (US)
- Environmental and Occupational Health Sciences Institute (US)
Publication Details
- Journal
- Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
- Published
- 2025-08-12
- DOI
- https://doi.org/10.1002/phar.70051
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00